Scientists Identify New Strategy To Develop Dengue Vaccines

Scientists have been able to detect antibodies against CRVP379 in human blood samples, demonstrating that it is able to elicit an immune response in humans.

Researchers from University of South Carolina and Central Michigan University have identified a protein that is essential for the spread of dengue infection in mosquitoes. Blocking this protein could be the strategy for developing dengue vaccines.

There is currently no approved specific treatment or vaccine for dengue fever, and an estimated two billion people are at risk for being bitten by Aedes mosquitoes and infected with the dengue virus (DENV).

Varanasi Municipal Corporation Stays Inactive as Dengue Threat Looms Large
Health department had initiated fogging drive. However, people claim that no measures were taken by civic body to check spread of mosquitoes in the city.

"These results further our understanding of DENV pathogenesis in the mosquito vector and highlight a potential target protein for the creation of a DENV transmission-blocking vaccine to break the host-vector transmission cycle," the researchers said.

Having previously identified a number of genes, the researchers now focused on one of them -- which they termed as CRVP379 -- that codes for a putative cysteine-rich venom protein.

The researchers reported that CRVP379 is required during DENV infection in mosquito cells and in live mosquitoes, and that there is a direct correlation between the amount of CRVP379 expressed in the mosquito gut (where infection initiates) and the level of DENV infection in the gut and in whole mosquitoes.

Taiwan Reports More Dengue Cases Since the Outbreak in May
Taiwan reported 261 new dengue cases, 150 in the city of Kaohsiung and 102 in Tainan. Two new dengue deaths were reported taking the death toll to 122.

They showed that CRVP379 interacts with a protein called prohibitin that is a putative DENV receptor in mosquitoes.

When the researchers fed Aedes mosquitoes antibodies able to recognize CRVP379, potentially blocking the interaction of the protein with either DENV or prohibitin, they found that this inhibits DENV infection of the mosquitoes.

13,607 Total Dengue Cases, Highest in History Since 1996 in the National Capital
According to the report by NDMC, till October 17, the number of houses found positive for mosquito breeding stood at 2,22,732 in Delhi.

Moreover, the scientists have been able to detect antibodies against CRVP379 in human blood samples, demonstrating that the protein is able to elicit an immune response in humans. The study was published in the journal PLOS Pathogens.

Source-IANS

Dengue Cases Cross Over 26,000 Mark In Taiwan: Centers For Disease Control
Dengue outbreak is concentrated in the cities of Kaohsiung and Tainan. Dengue has claimed 122 lives and 24,521 patients have recovered from the disease in Taiwan.